Physician profile
Matthew Hammond
NPI 1902483001
$14,973.00
in general payments reported to CMS, 2019-2025
13 companies · $1,889 in 2025
The $1,889 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $11K · 2023: $529 · 2024: $1,141 · 2025: $1,889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,906 · Education: $650 · Travel and Lodging: $2.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,906.30 |
| Education | $649.97 |
| Travel and Lodging | $2.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $10,958.15 | 2022-2025 | |
| Stryker Corporation | $933.56 | 2022-2025 | Gamma, Blueprint Patient Specific Instrumentation, Aequalis Ascend Flex |
| Zimmer Biomet Holdings, INC. | $892.04 | 2024-2025 | Persona, Juggerknotless Soft Anchor, Oxford |
| Medical Device Business Services, INC. | $649.97 | 2024-2025 | Actis |
| Pacira Pharmaceuticals Incorporated | $349.39 | 2022-2025 | Exparel, Iovera |
| Avanos Medical | $283.34 | 2023-2024 | On-Q* Pump and Accessories |
| Depuy Synthes Sales INC. | $277.71 | 2024-2025 | Na, Healix Knotless Peek |
| Innovation Technologies INC | $145.41 | 2022 | |
| Si-Bone, INC. | $134.44 | 2024 | |
| Heron Therapeutics, INC. | $121.35 | 2024 | Zynrelef |
| Kci USA, INC. | $94.50 | 2022 | |
| Smith+Nephew, INC. | $75.11 | 2022 | |
| Ethicon US, LLC | $58.03 | 2025 | Surgiflo Hemostatic Matrix, Ethicon, Megadyne |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hammond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.